AN UNBIASED VIEW OF PF-05221304

[61] demonstrated the CRISPR/Cas9 system could particularly goal and cleave conserved regions inside the HBV genome, resulting in strong suppression of viral gene expression and replication both equally in vitro As well as in vivoIn addition, this technique could inactivate the mutation of residual viral DNA. They concluded that CRISPR/Cas9 techniq